Cargando…

Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States

INTRODUCTION: Few studies have described chronic idiopathic/spontaneous urticaria (CIU/CSU) healthcare burden in adults, while this information remains largely unknown in children. We aimed to describe treatment patterns, healthcare resource utilization (HRU), and costs in CIU/CSU pediatric patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Paul V., Kavati, Abhishek, Pilon, Dominic, Xiao, Yongling, Zhdanava, Maryia, Balp, Maria-Magdalena, Lefebvre, Patrick, Ortiz, Benjamin, Hernandez-Trujillo, Vivian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825330/ https://www.ncbi.nlm.nih.gov/pubmed/29429043 http://dx.doi.org/10.1007/s13555-018-0225-6

Ejemplares similares

Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab
por: Kavati, Abhishek, et al.
Publicado: (2018)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
por: Hawe, Emma, et al.
Publicado: (2016)

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States
por: Zhdanava, Maryia, et al.
Publicado: (2023)

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
por: Pilon, Dominic, et al.
Publicado: (2017)

Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
por: Pilon, Dominic, et al.
Publicado: (2022)

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
por: Alberts, Mark, et al.
Publicado: (2023)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study
por: Alberts, Mark, et al.
Publicado: (2023)

Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study
por: Alberts, Mark, et al.
Publicado: (2023)

Comparison of Postpartum Health Care Use and Spending Among Individuals with Medicaid-Paid Births Enrolled in Continuous Medicaid vs Commercial Insurance
por: Gordon, Sarah H., et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Medicaid spending on contraceptive coverage and pregnancy-related care
por: Laliberté, François, et al.
Publicado: (2014)

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
por: Zhdanava, Maryia, et al.
Publicado: (2020)

Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling
por: Stull, Donald E., et al.
Publicado: (2016)

Medicaid Spending: A Brief History
por: Klemm, John D.
Publicado: (2000)

Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression
por: Zhdanava, Maryia, et al.
Publicado: (2021)

Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA
por: Zhdanava, Maryia, et al.
Publicado: (2021)

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
por: Broder, Michael S., et al.
Publicado: (2015)

The Effect of Medicaid Enrollment on Family Caregiving
por: Jutkowitz, Eric, et al.
Publicado: (2021)

Gene expression profiles in chronic idiopathic (spontaneous) urticaria
por: Patel, Ojas P., et al.
Publicado: (2015)

Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
por: Gimenéz-Arnau, Ana M., et al.
Publicado: (2016)

Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
por: Balp, Maria-Magdalena, et al.
Publicado: (2021)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

COVID‐19‐related Medicaid enrollment in Medicaid expansion and non‐expansion states
por: Benitez, Joseph A., et al.
Publicado: (2022)

Medicaid hospital spending: Effects of reimbursement and utilization control policies
por: Zuckerman, Stephen
Publicado: (1987)

Medicaid, the uninsured, and national health spending: Federal policy implications
por: Garrison, Louis P.
Publicado: (1990)

Medicaid Prescription Drug Spending in the 1990s: A Decade of Change
por: Baugh, David K., et al.
Publicado: (2004)

Association of State Medicaid Expansion With Hospital Community Benefit Spending
por: Kanter, Genevieve P., et al.
Publicado: (2020)

Trends in Medicaid spending on inhalers in the United States, 2012-2018
por: Sistani, Farideh, et al.
Publicado: (2021)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria
por: Finlay, A.Y., et al.
Publicado: (2017)

Data View: Medicaid Spending and Utilization for Central Nervous System Drugs
por: Baugh, David K., et al.
Publicado: (2004)

Medicaid and Pregnant Women: Who is Being Enrolled and When
por: Ellwood, Marilyn Rymer, et al.
Publicado: (1995)

Longitudinal patterns of enrollment and expenditures for a Medicaid cohort
por: Howell, Embry M., et al.
Publicado: (1988)

Association of Indiana’s Section 1115 Waiver With Medicaid Enrollment
por: Stimpson, Jim P., et al.
Publicado: (2019)

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
por: Ke, Xuehua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8k59119akl0d7md3lg79evejnn